ArticleHuman vaccines & immunotherapeutics2025
Vaccine hesitancy and economic hardship: A latent class analysis of racial and ethnic minority communities at high risk of COVID-19 infection in Southern California.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05022472 (Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
We examined the association between economic hardship and vaccine hesitancy among communities at high risk of COVID-19 infection. We used latent class analysis to calculate the predicted probability of belonging in a high or low vaccine hesitancy group using nine vaccine belief and behavior survey items using data from clinical trial NCT05022472. An economic hardship index was constructed to assess whether experiencing one or more economic hardships during the COVID-19 pandemic was associated with high vaccine hesitancy using a multivariable logistic regression model. Overall, 39% of participants remained highly vaccine hesitant despite vaccine uptake exceeding 97%, highlighting the important distinction between uptake and hesitancy. Having experienced at least one economic hardship significantly increased the adjusted odds of high vaccine hesitancy, compared to not experiencing any economic hardships. Employment, infection history, education, and vaccine series completion factors were also salient factors associated with high vaccine hesitancy. Future research should explore the impact of targeted financial and policy interventions in fostering vaccine confidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.